Monogram Orthopaedics Inc ( (MGRM) ) has released a notification of late filing.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Monogram Orthopaedics Inc. has filed a Form 12b-25 to notify the delay in submitting its Form 10-Q (Quarter Report) for the financial period ending June 30, 2025. The delay is attributed to unforeseen events that have made it challenging for the company to complete the report without incurring unreasonable effort and expense. The company anticipates filing the delayed report within five calendar days following the prescribed due date. Importantly, the company does not expect any significant changes in its financial results compared to the same period last year. Monogram Orthopaedics Inc. is committed to maintaining compliance, as indicated by the signature of its CEO, Benjamin Sexson, on the notification.
The most recent analyst rating on (MGRM) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Monogram Orthopaedics Inc stock, see the MGRM Stock Forecast page.
Spark’s Take on MGRM Stock
According to Spark, TipRanks’ AI Analyst, MGRM is a Neutral.
Monogram Orthopaedics Inc. shows promise due to significant technological advancements and recent regulatory clearances, which are key drivers for potential growth. However, financial instability, regulatory uncertainties, and ongoing profitability challenges weigh heavily on the overall score. The stock’s upward momentum is a positive indicator, but valuation metrics remain weak due to negative earnings and lack of dividends.
To see Spark’s full report on MGRM stock, click here.
More about Monogram Orthopaedics Inc
Average Trading Volume: 365,830
Technical Sentiment Signal: Buy
For a thorough assessment of MGRM stock, go to TipRanks’ Stock Analysis page.